Allogeneic stem cell transplantation in AML - immunosuppression with Rapamycin as alternative to calcineurin inhibitors

被引：0
|
作者：
Reibke, R. [1 ]
Franko, L. [1 ]
Tischer, J. [1 ]
Kolb, H-J [2 ]
机构：
[1] Univ Hosp Munich, Dept Internal Med 3, Munich, Germany
[2] Tech Univ Munich, Dept Internal Med 3, Munich, Germany
来源：
ONKOLOGIE | 2012年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：210 / 211
页数：2
相关论文
共 50 条
  • [41] Transcriptional Immunoediting of AML Cells after Allogeneic Hematopoietic Stem Cell Transplantation
    Eagle, Kenneth
    Harada, Taku
    Kalfon, Jeremie
    Perez, Monika
    Heshmati, Yaser
    Ewers, Jazmin
    Stegmaier, Kimberly
    Orkin, Stuart H.
    Pimkin, Maxim
    BLOOD, 2021, 138
  • [42] Generalist in allogeneic hematopoietic stem cell transplantation for MDS or AML: Epigenetic therapy
    Yang, Guancui
    Wang, Xiang
    Huang, Shiqin
    Huang, Ruihao
    Wei, Jin
    Wang, Xiaoqi
    Zhang, Xi
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [43] Allogeneic Hematopoietic Stem Cell Transplantation for Adult AML Patients with Granulocytic Sarcoma
    Shimizu, Hiroaki
    Saitoh, Takayuki
    Tanaka, Masatsugu
    Mori, Takehiko
    Kawai, Nobutaka
    Sakura, Toru
    Kanda, Yoshinobu
    Nakaseko, Chiaki
    Yano, Shingo
    Fujita, Hiroyuki
    Fujisawa, Shin
    Miyawaki, Shuichi
    Kanamori, Heiwa
    Okamoto, Shinichiro
    BLOOD, 2011, 118 (21) : 890 - 891
  • [44] PRCA after allogeneic stem cell transplantation for AML successfully treated with rituximab
    Krawczyk-Kulis, M
    Markiewicz, M
    Nowak, K
    Kruzel, T
    Holowiecki, J
    BONE MARROW TRANSPLANTATION, 2005, 35 : S354 - S354
  • [45] DRUG INTERACTION BETWEEN ORAL CALCINEURIN INHIBITORS (TACROLIMUS AND CYCLOSPORINE A) AND ORAL VORICONAZOLE IN THE RECIPIENTS OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Mori, T.
    Kato, J.
    Aisa, Y.
    Yamane, A.
    Ono, Y.
    Okamoto, S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S260 - S261
  • [46] Outcomes of calcineurin inhibitors conversion to mammalian target of rapamycin inhibitors in children with renal transplantation
    Piyaphanee, Nuntawan
    Supavekin, Suroj
    Pattaragarn, Anirut
    PEDIATRIC NEPHROLOGY, 2013, 28 (08) : 1517 - 1518
  • [47] Calcineurin Inhibitors Replacement by Ruxolitinib as Graft-versus-Host Disease Prophylaxis for Patients after Allogeneic Stem Cell Transplantation
    Zhao, Yanmin
    Shi, Jimin
    Luo, Yi
    Gao, Fei
    Tan, Yamin
    Lai, Xiaoyu
    Yu, Jian
    Wei, Guoqing
    Huang, He
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (05) : E128 - E133
  • [48] HCC recurrence after liver transplantation: Role of immunosuppression with calcineurin inhibitors
    Vivarelli, M.
    Cucchetti, A.
    La Barba, G.
    Cescon, M.
    Del Gaudio, M.
    Ercolani, G.
    Lauro, A.
    Ravaioli, M.
    Grazi, G. L.
    Pinna, A. D.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S98 - S99
  • [49] Outcomes of allogeneic stem cell transplantation for patients with t(6:9) AML- A strong case for allogeneic stem cell transplantation in first complete remission
    Stahl, Maximilian
    Tallman, Martin S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (05) : 806 - 808
  • [50] Foscarnet -: an alternative for cytomegalovirus prophylaxis after allogeneic stem cell transplantation?
    Ordemann, R
    Naumann, R
    Geissler, G
    Kroschinsky, F
    Bornhäuser, M
    Schwerdtfeger, R
    Ehninger, G
    ANNALS OF HEMATOLOGY, 2000, 79 (08) : 432 - 436
12345